Detomidine hydrochloride
CAS: 90038-01-0
Ref. 3D-FD21398
| 1g | Descontinuado | ||
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
Detomidine hydrochloride
Sinónimos:
- 5-[(2,3-Dimethylphenyl)methyl]-1H-imidazole hydrochloride4-[(2,3-Dimethylphenyl)methyl]-1H-imidazole monohydrochlorideDomosedan
- 1H-Imidazole, 4-[(2,3-dimethylphenyl)methyl]-, monohydrochloride
- 1H-Imidazole, 5-[(2,3-dimethylphenyl)methyl]-, hydrochloride (1:1)
- 4-[(2,3-Dimethylphenyl)methyl]-1H-imidazole monohydrochloride
- 5-(2,3-dimethylbenzyl)-1H-imidazole hydrochloride (1:1)
- Domosedan
- Dormosedan
- Mpv 253Aii
Descrição:
Detomidine hydrochloride is a sedative that is used to manage pain in animals. It has a clinical relevance in the treatment of convulsions, seizures, and tetanus. Detomidine hydrochloride has been shown to have 2-adrenergic receptor agonist activity and can cause the release of energy substrates from cells. The drug also alters cardiac function by causing an increase in blood pressure, heart rate, and cardiac output. Detomidine hydrochloride has been shown to alter microdialysis probes for physiological effects such as estradiol benzoate concentration and cortisol concentrations. This drug also has locomotor activity effects on rats that can be inhibited with nonsteroidal anti-inflammatory drugs such as ibuprofen.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
222.71 g/mol
Fórmula:
C12H15ClN2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
